Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Cannabinoids in the management of difficult to treat pain.
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis.
The Neuroepithelium Disruption Could Generate Autoantibodies against AQP4 and Cause Neuromyelitis Optica and Hydrocephalus.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Polyunsaturated fatty acids in multiple sclerosis therapy.
[Neuromyelitis optica.]
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
First patient enrolled in third Phase III study of oral laquinimod for relapsing-remitting multiple sclerosis
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.
What to expect after natalizumab cessation in a real-life setting.
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
Validity and variability of the 5-repetition sit-to-stand test in patients with multiple sclerosis.
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
Review of MR elastography applications and recent developments.
Neurofilaments as biomarkers in multiple sclerosis.
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Metals and Neurodegeneration.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »